Close



Mar 19, 2024 04:02PM
Feb 8, 2024 04:06PM
Feb 8, 2024 04:05PM
Nov 7, 2023 04:01PM
Nov 2, 2023 04:21AM
Nov 1, 2023 07:31PM
Sep 6, 2023 04:05PM Corvus Pharmaceuticals Confirms Planned Initiation of Soquelitinib (CPI-818) Phase 3 Registrational Clinical Trial in Peripheral T Cell Lymphoma Following Meeting with FDA
Aug 8, 2023 04:01PM
Jul 6, 2023 01:02PM
Jul 6, 2023 12:59PM
Jun 15, 2023 07:03AM
Jun 15, 2023 07:00AM
May 17, 2023 09:00AM
May 8, 2023 04:01PM Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2023 Financial Results
Apr 17, 2023 09:01AM
Apr 17, 2023 09:00AM
Mar 28, 2023 04:02PM
Sep 26, 2022 05:44PM
Sep 17, 2021 09:28AM
Jul 16, 2021 09:30AM
Apr 29, 2021 04:05PM Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2021 Financial Results
Mar 25, 2021 08:30AM
Feb 12, 2021 09:19AM
Feb 4, 2021 07:40AM
Feb 4, 2021 07:30AM
Dec 29, 2020 07:42AM
Dec 6, 2020 10:00AM
Nov 11, 2020 04:05PM Corvus Hosting R&D Symposium on November 12 to Highlight COVID-19 Program and Updated Study Data Presented at SITC Annual Meeting
Nov 9, 2020 08:05AM
Oct 29, 2020 04:00PM
Oct 5, 2020 07:25AM
Oct 5, 2020 07:24AM
Sep 17, 2020 06:10AM
Sep 17, 2020 03:01AM
Sep 10, 2020 08:31AM Corvus Pharma (CRVS) Announces Update on Clinical Trial of CPI-006 for Patients with COVID-19
Sep 10, 2020 08:30AM
Jul 30, 2020 04:02PM
Jul 7, 2020 07:07AM
Jul 7, 2020 07:00AM
Apr 30, 2020 04:05PM
Feb 19, 2020 04:05PM
Dec 9, 2019 06:15AM Corvus Pharma (CRVS) Announces Preclinical & Initial Clinical Data from Phase 1/1b Trial of CPI-818
Dec 7, 2019 09:00AM
Oct 29, 2019 04:05PM
Aug 1, 2019 04:05PM
May 9, 2019 04:02PM
Mar 7, 2019 04:10PM
Jan 28, 2019 04:05PM
Jan 10, 2019 08:30AM Corvus Announces Presentation of Preclinical Data on CPI-818, a First-in-class Covalent Inhibitor of ITK Targeting T-Cell Lymphomas
Feb 1, 2018 08:30AM

251,738 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All